Owen A. O’Connor

Also affiliated with University of Virginia Cancer Center, University of Virginia

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies”.

Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3706

N/A

4.4DataRank · unranked

198 citations

Michael B. Maris, Alexander M. Lesokhin, Robert W. Chen, Ian W. Flinn, Ahmed Sawas +21 more

Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

Blood Advances(2022)10.1182/bloodadvances.2020003971

N/A

1.1DataRank · unranked

40 citations

Steven M. Horwitz, Ranjana H. Advani, Jacob Haaber Christensen, Eva Domingo‐Doménech, Giuseppe Rossi +19 more

Targeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0377

N/A

0DataRank · unranked

20 citations

Cristina Kinahan, Eugene F. Douglass, Changchun Deng, Maryam Safari, Beatrice Casadei +10 more

Data from Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

(2023)10.1158/1078-0432.c.6531017.v1

N/A

0DataRank · unranked

0 citations

Michael B. Maris, Alexander M. Lesokhin, Robert W. Chen, Ian W. Flinn, Ahmed Sawas +21 more

Data from Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

(2023)10.1158/1078-0432.c.6531017

N/A

0DataRank · unranked

0 citations

Michael B. Maris, Alexander M. Lesokhin, Robert W. Chen, Ian W. Flinn, Ahmed Sawas +21 more

N-quinoline-benzenesulfonamide derivatives exert potent anti-lymphoma effect by targeting NF-κB

iScience(2020)10.1016/j.isci.2020.101884

N/A

0DataRank · unranked

3 citations

Michael Mangone, Alison Rinderspacher, Shi‐Xian Deng, Luigi Scotto, Michael Markson +5 more

Management of T‐cell malignancies: Bench‐to‐bedside targeting of epigenetic biology

CA A Cancer Journal for Clinicians(2025)10.3322/caac.70001

N/A

0DataRank · unranked

3 citations

Johnson Ung, Jeffrey W. Craig, Kallesh D. Jayappa, Ipsita Pal, Thomas P. Loughran +3 more

R-Loop–Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-20-0833

N/A

0DataRank · unranked

31 citations

Thomas Litman, Robert W. Robey, Andrés Aguilera, Arup R. Chakraborty, William C. Reinhold +8 more